Skip to main content
SpringerLink
Log in

Epidemiology of Cervical Cancer

  • Chapter
  • First Online:
Uterine Cervical Cancer

Abstract

Worldwide, cervical cancer is the fourth most common cancer among women, with an estimated 528,000 new cases (7.9% of cancer in women) and 266,000 deaths (7.5% of cancer deaths in women) in the year 2012 and a 5-year prevalence of 1.5 million cases (9% of women with cancer). About 85% of the cases occur in developing countries, where cervical cancer accounts for 12% of all cancers in women. The cervical and endometrial cancers originate in the uterus but differ drastically in terms of aetiology, clinical presentation and characteristics, prognosis and survival. Cervical cancer is a model of viral carcinogenesis and most common in developing countries, whereas endometrial cancer is a model of hormonal carcinogenesis and most common in developed countries. The aim of this chapter is to provide an overview of key concepts in cancer epidemiology and to describe the global patterns and trends in incidence and mortality, aetiology and prevention of cervical cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Memon A. Epidemiological understanding: an overview of basic concepts and study designs. In: Pencheon D, et al., editors. Oxford handbook of public health practice. 2nd ed. Oxford: Oxford University Press; 2006. p. 100–11.

    Google Scholar 

  2. Memon A. Epidemiology of gynaecological cancers. In: Shafi M, et al., editors. Gynaecological oncology. Cambridge: Cambridge University Press; 2010. p. 1–13.

    Google Scholar 

  3. Forman D, Bray F, Vrewster D, et al. Cancer incidence in five continents, Vol X (electronic version) Lyon, IARC. 2013. Available from: http://ci5.iarc.fr/CI5-X

  4. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr

  5. The Surveillance, Epidemiology, and End Results (SEER) Program. Available from: http://seer.cancer.gov

  6. National Cancer Institute. Cervical cancer. 2014. Available from: http://www.cancer.gov/cancertopics/types/cervical

  7. Centers for Disease Control and Prevention (CDC), National Programme of Cancer Registries (NPCR). Available from: http://apps.nccd.cdc.gov/uscs and http://www.cdc.gov/cancer/npcr

  8. Ryerson A, Eheman C, Altekruse S, et al. Annual report to the nation on the status of cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer. 2016;122(9):1312–37.

    Article  Google Scholar 

  9. Ylitalo N, Stuver S, Adami H. Cervical cancer. In: Hans-Olov A, et al., editors. Textbook of cancer epidemiology. 2nd ed. New York: Oxford University Press; 2008. p. 446–67.

    Chapter  Google Scholar 

  10. Cancer Research UK. Available from: http://info.cancerresearchuk.org

  11. Schiffman M, Castle P, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890–907.

    Article  CAS  Google Scholar 

  12. Castle P, Rodriguez A, Burk R, et al. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ. 2009;339:b2569.

    Article  Google Scholar 

  13. Crosbie E, Einstein M, Franceschi S, et al. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889–99.

    Article  Google Scholar 

  14. Guan P, Howell-Jones R, Li N, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349–59.

    Article  CAS  Google Scholar 

  15. Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128(4):927–35.

    Article  CAS  Google Scholar 

  16. Cox J. The development of cervical cancer and its precursors: what is the role of human papillomavirus infection? Curr Opin Obstet Gynecol. 2006;18(suppl.1):S5–S13.

    Article  Google Scholar 

  17. Sellors J, Karwalajtys T, Kaczorowski J, et al. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ. 2003;168(4):421–5.

    PubMed  PubMed Central  Google Scholar 

  18. Dunne E, Unger E, Stenberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813–9.

    Article  CAS  Google Scholar 

  19. Plummer M, de Martel C, Vignat J, et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):609–16.

    Article  Google Scholar 

  20. Franceschi S, Herrero R, Clifford G, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006;119(11):2677–84.

    Article  CAS  Google Scholar 

  21. De Sanjose S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453–9.

    Article  Google Scholar 

  22. International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer. 2006; 118 6 :1481–95.

    Google Scholar 

  23. Kapeu A, Luostarinen T, Jellum E, et al. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol. 2008;169(4):480–8.

    Article  Google Scholar 

  24. Plummer M, Herrero R, Franceschi S, et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control. 2003;14(9):805–14.

    Article  Google Scholar 

  25. Schiffman M, Brinton L. The epidemiology of cervical carcinogenesis. Cancer. 1995;76(suppl.10):1888–901.

    Article  CAS  Google Scholar 

  26. Palefsky J, Holly E. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomark Prev. 1995;4(4):415–28.

    CAS  Google Scholar 

  27. Burger M, Hollema H, Gouw A, et al. Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. BMJ. 1993;306(6880):749–52.

    Article  CAS  Google Scholar 

  28. International Agency for Research on Cancer. Human papillomavirus. IARC monographs. 2012; 100b:255–313.

    Google Scholar 

  29. De Vuyst H, Gichangi P, Estambale B, et al. Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya. Int J Cancer. 2008;122(1):244–6.

    Article  Google Scholar 

  30. Sun X, Kuhn L, Ellerbrock T, et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997;337(19):1343–9.

    Article  CAS  Google Scholar 

  31. Rohner E, Sengayi M, Goeieman B, et al. Cervical cancer risk and impact of pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa. Int J Cancer. 2017;141(3):488–96.

    Article  CAS  Google Scholar 

  32. Strickler H, Palefsky J, Shah K, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst. 2003;95(14):1062–71.

    Article  Google Scholar 

  33. Dahlstrom L, Andersson K, Luostarinen T, et al. Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer. Cancer Epidemiol Biomark Prev. 2011;20(12):2541–50.

    Article  Google Scholar 

  34. Smith J, Bosetti C, Munoz N, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer. 2004;111(3):431–9.

    Article  CAS  Google Scholar 

  35. Smith J, Munoz N, Herrero R, et al. Evidence for chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis. 2002;185m(3):324–31.

    Article  Google Scholar 

  36. Wallin K, Wiklund F, Luostarinen T, et al. A population-based prospective study of chlamydia trachomatis infection and cervical carcinoma. Int J Cancer. 2002;101(4):371–4.

    Article  CAS  Google Scholar 

  37. Koskela P, Anttila T, Bjorge T, et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer. 2000;85(1):35–9.

    Article  CAS  Google Scholar 

  38. Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002;359(9312):1093–101.

    Article  Google Scholar 

  39. Silins I, Ryd W, Strand A, et al. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer. 2005;116(1):110–5.

    Article  CAS  Google Scholar 

  40. Winer R, Hughes J, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med. 2006;354(25):2645–54.

    Article  CAS  Google Scholar 

  41. Ursin G, Pike M, Preston-Martin S, et al. Sexual, reproductive and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States). Cancer Causes Control. 1996;7(3):391–401.

    Article  CAS  Google Scholar 

  42. Lee J, So K, Piyathilake C, et al. Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer. PLoS One. 2013;8(6):e66555.

    Article  CAS  Google Scholar 

  43. Garcia-Closas R, Castellsague X, Bosch X, et al. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer. 2005;117(4):629–37.

    Article  CAS  Google Scholar 

  44. Peirson L, Fitzpatrick-Lewis D, Ciliska D, et al. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013;2:35.

    Article  Google Scholar 

  45. NHS Choices. Available from: http://www.nhs.uk/pages/home.aspx

  46. Landy R, Pesola F, Castanon A, et al. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study. Br J Cancer. 2016;115(9):1140–6.

    Article  Google Scholar 

  47. Leeman A, del Pino M, Molijn A, et al. HPV testing in first-void urine provides sensitivity for CIN2+detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population. BJOG. 2017;124(9):1356–63.

    Article  CAS  Google Scholar 

  48. Blake D, Crosbie E, Kitson S. Urinary HPV testing may offer hope for cervical screening non-attenders. BJOG. 2017;124(9):1364.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, UK

    Anjum Memon & Peter Bannister

Authors
  1. Anjum Memon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Bannister
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anjum Memon .

Editor information

Editors and Affiliations

  1. The Joan and Sanford I. Weill Medical College/Graduate School of Medical Sciences, The New York Presbyterian Hospital-Weill Cornell Medical Center, and Sandra and Edward Meyer Cancer Center, Cornell University, New York, NY, USA

    Samir A. Farghaly

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Memon, A., Bannister, P. (2019). Epidemiology of Cervical Cancer. In: Farghaly, S. (eds) Uterine Cervical Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-02701-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-02701-8_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-02700-1

  • Online ISBN: 978-3-030-02701-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation